Novel dimeric DOTA-coupled peptidic Y1-receptor antagonists for targeting of neuropeptide Y receptor-expressing cancers
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2191-219X
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Novel dimeric DOTA-coupled peptidic Y1-receptor antagonists for targeting of neuropeptide Y receptor-expressing cancers ; volume:1 ; number:1 ; day:2 ; month:9 ; year:2011 ; pages:1-11 ; date:12.2011
EJNMMI Research ; 1, Heft 1 (2.9.2011), 1-11, 12.2011
- Creator
-
Chatenet, David
Cescato, Renzo
Waser, Beatrice
Erchegyi, Judit
Rivier, Jean E.
Reubi, Jean Claude
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/2191-219X-1-21
- URN
-
urn:nbn:de:101:1-2021081411593455062572
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:51 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Chatenet, David
- Cescato, Renzo
- Waser, Beatrice
- Erchegyi, Judit
- Rivier, Jean E.
- Reubi, Jean Claude
- SpringerLink (Online service)
Other Objects (12)
Leukotriene Receptor Antagonists
Piperazine‐based P2X4 receptor antagonists
Investigation of the binding site of agonists and antagonists at the human neuropeptide Y receptor family
Mineralocorticoid receptor antagonists in dialysis patients
Why are mineralocorticoid receptor antagonists cardioprotective?
Neurokinin 1 Receptor Antagonists for Pruritus
Structural characterization of neuropeptide Y receptor activation
Azologization of serotonin 5-HT3 receptor antagonists
Irreversible Antagonists for the Adenosine A2B Receptor
Regulation of neuropeptide Y receptor activation and trafficking
Molecular characterization of the human neuropeptide Y5 receptor
Mineralocorticoid receptor overactivation: targeting systemic impact with non-steroidal mineralocorticoid receptor antagonists
Leukotriene Receptor Antagonists
Piperazine‐based P2X4 receptor antagonists
Investigation of the binding site of agonists and antagonists at the human neuropeptide Y receptor family
Mineralocorticoid receptor antagonists in dialysis patients
Why are mineralocorticoid receptor antagonists cardioprotective?
Neurokinin 1 Receptor Antagonists for Pruritus
Structural characterization of neuropeptide Y receptor activation
Azologization of serotonin 5-HT3 receptor antagonists
Irreversible Antagonists for the Adenosine A2B Receptor
Regulation of neuropeptide Y receptor activation and trafficking
Molecular characterization of the human neuropeptide Y5 receptor
Mineralocorticoid receptor overactivation: targeting systemic impact with non-steroidal mineralocorticoid receptor antagonists
Leukotriene Receptor Antagonists
Piperazine‐based P2X4 receptor antagonists
Investigation of the binding site of agonists and antagonists at the human neuropeptide Y receptor family
Mineralocorticoid receptor antagonists in dialysis patients
Why are mineralocorticoid receptor antagonists cardioprotective?
Neurokinin 1 Receptor Antagonists for Pruritus
Structural characterization of neuropeptide Y receptor activation
Azologization of serotonin 5-HT3 receptor antagonists
Irreversible Antagonists for the Adenosine A2B Receptor
Regulation of neuropeptide Y receptor activation and trafficking
Molecular characterization of the human neuropeptide Y5 receptor